ArticleTherapeutic advances in drug safety2026

Drug- and patient-specific neurological risk profiles of α1-adrenergic blockers: evidence from FAERS and external validation in JADER.

Xin Hai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.